Tom Isett

SENIOR ADVISOR

Tom brings over 25 years of experience in management and strategy development to his role at Adjuvant Partners. With a deep appreciation of the differing execution challenges that exist for Life Science organizations of all types and sizes, Tom is able to help craft executable strategies that reliably deliver results. His insights have been sought after by Fortune 500 companies, CROs, standards-setting organizations, CDMOs, startup, and institutional investors, alike, and he is a member of the NIH's NHLBI Mentor Network.

In addition, Tom is currently the Managing Director of i.e. Advising, a strategy and management consulting firm focused on supporting life sciences companies and investors. Prior founding i.e. Advising in 2015, and Commence Bio, Inc., Tom led GE's $500M North American BioProcess business where he introduced the Integrated Solutions strategy. As Lonza's Head of Cell Processing Technologies and Cell Culture Media businesses, he was in the forefront of helping cell & gene therapy developers meet their clinical development and manufacturing needs.  Previoulsy, Tom led Becton Dickinson's Core Microbiology business and was the Founder and VP of the company's Advanced Bioprocessing unit. Tom holds a BSc in Biological Sciences from Drexel University, and as an undergrad, published on plant sciences as part of his work with the USDA and focused on microbiology while at GSK.